Search results
PLI scheme for obesity, diabetes drugs likely by 2026: Report
Business Today· 1 day agoIndian pharma companies such as Dr. Reddy's Laboratories, Lupin, Zydus Cadila, and Sun Pharma are...
Stock market update: Nifty Pharma index advances 1.11%
The Economic Times· 1 day agoThe Nifty Pharma index closed 1.11 per cent up at 19731.55.
Lupin fined 40 Million Euros by EU court for anti-competitive drug deal | India Infoline
India Infoline· 1 day agoLupin must pay 40 million euros plus accrued interest to the European Commission.
India plans incentives for diabetes, obesity drug makers in 2026, government official says - ET...
The Economic Times· 1 day agoBengaluru: India is planning to offer incentives to promote local manufacturing of GLP-1 drugs used...
European Court of Justice upholds 40 million Euro fine on Lupin | India Infoline
India Infoline· 1 day agoThe European Court of Justice confirmed the European Commission’s decision to impose a 40 million euro fine on Lupin Limited. This decision was made in connection with a patent ...
Lupin loses appeal in EU court, will have to pay €40 mn fine in Perindopril case - CNBC TV18
CNBC TV18· 1 day agoThe European Court of Justice has upheld the European Commission’s decision to impose a fine of 40...
PLI scheme to make obesity, diabetes drugs GLP-1 coming in 2026
CNBC Awaaz· 1 day agoGlucagon-like peptide-1 (GLP-1) are a category of drugs used in the treatment of type 2 diabetes and...
Lupin shares gain 1.77% as Sensex rises
The Economic Times· 1 day agoA total of 34,891 shares changed hands on the counter till 10:35AM (IST)
Stock market update: Nifty Pharma index advances 1.37% in an upbeat market
The Economic Times· 1 day agoThe Nifty Pharma index was trading 1.37 per cent up at 19782.05.
Apple TV+ French Drama ‘A L’ombre Des Forêts’: All you may want to know about plot, cast and crew
The Economic Times· 2 days agoApple TV+ announces a new French original series, 'A L’ombre Des Forêts', starring Benoît Magimel...